NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Varun Beverages Posts Strong Quarter, Raises Earnings Estimates

Varun Beverages (VBL) has reported a robust quarter, driven by significant volume growth across both domestic and international markets. The company's consolidated volume growth stood at approximately 16% year-over-year (YoY), with a notable 14.4% increase in India and a substantial 21.4% rise in international territories.

The company's net realization per case saw a 1.6% improvement at the consolidated level, primarily due to favorable currency movements in international territories. However, this gain was partially offset by a 1.5% dip in net realizations in India, resulting from pack upsizing and targeted price-point launches.

Motilal Oswal's Research Team Raises Earnings Estimates

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Based on the company's performance, Motilal Oswal's research team has revised their earnings estimates for Varun Beverages. For the fiscal years 2025-2027, they project a compound annual growth rate (CAGR) of 16% in revenue, 16% in earnings before interest, taxes, depreciation, and amortization (EBITDA), and 20% in profit after tax (PAT).

MetricCY25CY26CY27
Revenue CAGR-16%16%
EBITDA CAGR-16%16%
PAT CAGR-20%20%

The research team has also increased their earnings estimates for CY26E and CY27E by 4% and 6%, respectively. They maintain a BUY rating on the stock with a target price of INR600 (47x CY26E earnings per share).

Investor Takeaway

Investors should consider buying Varun Beverages stock with a target price of INR600.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.